Rifampin/KLH is an antigen-adjuvant conjugate composed of Rifampin and keyhole limpet hemocyanin (KLH). Conjugating the antigen with the protein adjuvant enhances the production of antigen-specific antibodies in vaccine models. The conjugate does not disrupt protein folding or major epitopes and increases cross-presentation and antigen-specific T cell production.